Updated Jul 16, 2026
Goncalves Joana has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.03M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 300 | $87.25 | $26K |
| 2026-07-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.8K | $86.68 | $330K |
| 2026-07-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.5K | $85.86 | $214K |
| 2026-07-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale [10b5-1] | 400 | $84.36 | $34K |
| 2026-07-15 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise [10b5-1] | 3.5K | $7.80 | $27K |
| 2026-07-15 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise [10b5-1] | 3.5K | $6.84 | $24K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 947 | $69.69 | $66K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 300 | $70.62 | $21K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 5.1K | $69.42 | $352K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 1.6K | $68.38 | $112K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 3.5K | $7.80 | $27K |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 3.5K | $6.84 | $24K |
| 2026-05-16 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 100 | $63.52 | $6K |
| 2026-05-16 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 2.1K | $62.42 | $131K |
| 2026-05-16 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 4.8K | $61.56 | $295K |
| 2026-05-16 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 3.5K | $7.80 | $27K |
| 2026-05-16 | ORKA | Oruka Therapeutics, Inc. | M — Option exercise | 3.5K | $6.84 | $24K |
| 2026-04-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 500 | $67.38 | $34K |
| 2026-04-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 2.3K | $66.56 | $151K |
| 2026-04-15 | ORKA | Oruka Therapeutics, Inc. | S — Open-market sale | 4.2K | $65.73 | $278K |
Goncalves Joana is a corporate insider — currently tracked as Chief Medical Officer of Oruka Therapeutics, Inc. (ORKA). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 26 open-market sales ($3.03M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Goncalves Joana profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.